nodes	percent_of_prediction	percent_of_DWPC	metapath
Desloratadine—CYP1A2—chronic obstructive pulmonary disease	0.422	1	CbGaD
Desloratadine—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.0498	0.119	CbGbCtD
Desloratadine—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.0498	0.119	CbGbCtD
Desloratadine—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0414	0.0991	CbGbCtD
Desloratadine—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0414	0.0991	CbGbCtD
Desloratadine—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.039	0.0935	CbGbCtD
Desloratadine—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0378	0.0906	CbGbCtD
Desloratadine—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0378	0.0906	CbGbCtD
Desloratadine—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0337	0.0807	CbGbCtD
Desloratadine—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.0314	0.0751	CbGbCtD
Desloratadine—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.0209	0.05	CbGbCtD
Desloratadine—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.0179	0.0428	CbGbCtD
Desloratadine—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.0169	0.0404	CbGbCtD
Desloratadine—Connective tissue disorder—Arformoterol—chronic obstructive pulmonary disease	0.000471	0.00343	CcSEcCtD
Desloratadine—Hepatitis—Montelukast—chronic obstructive pulmonary disease	0.000469	0.00342	CcSEcCtD
Desloratadine—Hallucination—Montelukast—chronic obstructive pulmonary disease	0.000467	0.0034	CcSEcCtD
Desloratadine—Pharyngitis—Montelukast—chronic obstructive pulmonary disease	0.000465	0.0034	CcSEcCtD
Desloratadine—Connective tissue disorder—Montelukast—chronic obstructive pulmonary disease	0.000461	0.00336	CcSEcCtD
Desloratadine—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.000459	0.00335	CcSEcCtD
Desloratadine—Palpitations—Tiotropium—chronic obstructive pulmonary disease	0.000456	0.00333	CcSEcCtD
Desloratadine—Cough—Tiotropium—chronic obstructive pulmonary disease	0.000451	0.00329	CcSEcCtD
Desloratadine—Pharyngitis—Salbutamol—chronic obstructive pulmonary disease	0.000449	0.00327	CcSEcCtD
Desloratadine—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.000447	0.00326	CcSEcCtD
Desloratadine—Cardiac disorder—Arformoterol—chronic obstructive pulmonary disease	0.000444	0.00324	CcSEcCtD
Desloratadine—Cardiac disorder—Formoterol—chronic obstructive pulmonary disease	0.000444	0.00324	CcSEcCtD
Desloratadine—Connective tissue disorder—Salbutamol—chronic obstructive pulmonary disease	0.000444	0.00324	CcSEcCtD
Desloratadine—Infection—Aminophylline—chronic obstructive pulmonary disease	0.000444	0.00324	CcSEcCtD
Desloratadine—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000443	0.00323	CcSEcCtD
Desloratadine—Myalgia—Tiotropium—chronic obstructive pulmonary disease	0.00044	0.00321	CcSEcCtD
Desloratadine—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.000438	0.0032	CcSEcCtD
Desloratadine—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.000436	0.00318	CcSEcCtD
Desloratadine—Cardiac disorder—Montelukast—chronic obstructive pulmonary disease	0.000435	0.00318	CcSEcCtD
Desloratadine—Dry mouth—Tiotropium—chronic obstructive pulmonary disease	0.00043	0.00314	CcSEcCtD
Desloratadine—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000426	0.00311	CcSEcCtD
Desloratadine—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.000426	0.00311	CcSEcCtD
Desloratadine—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000423	0.00308	CcSEcCtD
Desloratadine—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000422	0.00308	CcSEcCtD
Desloratadine—Oedema—Tiotropium—chronic obstructive pulmonary disease	0.000422	0.00307	CcSEcCtD
Desloratadine—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00042	0.00306	CcSEcCtD
Desloratadine—Cardiac disorder—Salbutamol—chronic obstructive pulmonary disease	0.00042	0.00306	CcSEcCtD
Desloratadine—Mental disorder—Formoterol—chronic obstructive pulmonary disease	0.00042	0.00306	CcSEcCtD
Desloratadine—Mental disorder—Arformoterol—chronic obstructive pulmonary disease	0.00042	0.00306	CcSEcCtD
Desloratadine—Infection—Tiotropium—chronic obstructive pulmonary disease	0.000419	0.00305	CcSEcCtD
Desloratadine—Viral infection—Prednisone—chronic obstructive pulmonary disease	0.000415	0.00303	CcSEcCtD
Desloratadine—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.000413	0.00302	CcSEcCtD
Desloratadine—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.000411	0.003	CcSEcCtD
Desloratadine—Mental disorder—Montelukast—chronic obstructive pulmonary disease	0.000411	0.003	CcSEcCtD
Desloratadine—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.000404	0.00295	CcSEcCtD
Desloratadine—Increased appetite—Prednisolone—chronic obstructive pulmonary disease	0.000399	0.00291	CcSEcCtD
Desloratadine—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000398	0.0029	CcSEcCtD
Desloratadine—Mental disorder—Salbutamol—chronic obstructive pulmonary disease	0.000396	0.00289	CcSEcCtD
Desloratadine—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.000393	0.00287	CcSEcCtD
Desloratadine—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.000389	0.00283	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.000384	0.0028	CcSEcCtD
Desloratadine—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.000383	0.00279	CcSEcCtD
Desloratadine—Agitation—Formoterol—chronic obstructive pulmonary disease	0.000383	0.00279	CcSEcCtD
Desloratadine—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.000381	0.00278	CcSEcCtD
Desloratadine—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.000381	0.00278	CcSEcCtD
Desloratadine—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.000381	0.00278	CcSEcCtD
Desloratadine—Agitation—Montelukast—chronic obstructive pulmonary disease	0.000375	0.00274	CcSEcCtD
Desloratadine—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.000373	0.00272	CcSEcCtD
Desloratadine—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000371	0.00271	CcSEcCtD
Desloratadine—Affect lability—Prednisolone—chronic obstructive pulmonary disease	0.000369	0.00269	CcSEcCtD
Desloratadine—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.000368	0.00269	CcSEcCtD
Desloratadine—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.000368	0.00269	CcSEcCtD
Desloratadine—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000366	0.00267	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000364	0.00265	CcSEcCtD
Desloratadine—Cough—Arformoterol—chronic obstructive pulmonary disease	0.000364	0.00265	CcSEcCtD
Desloratadine—Cough—Formoterol—chronic obstructive pulmonary disease	0.000364	0.00265	CcSEcCtD
Desloratadine—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.000362	0.00264	CcSEcCtD
Desloratadine—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.000361	0.00263	CcSEcCtD
Desloratadine—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.00036	0.00262	CcSEcCtD
Desloratadine—Cough—Montelukast—chronic obstructive pulmonary disease	0.000356	0.0026	CcSEcCtD
Desloratadine—Mood swings—Prednisolone—chronic obstructive pulmonary disease	0.000355	0.00259	CcSEcCtD
Desloratadine—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000355	0.00259	CcSEcCtD
Desloratadine—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000355	0.00259	CcSEcCtD
Desloratadine—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000355	0.00259	CcSEcCtD
Desloratadine—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000354	0.00258	CcSEcCtD
Desloratadine—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000353	0.00258	CcSEcCtD
Desloratadine—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000353	0.00258	CcSEcCtD
Desloratadine—Amoxapine—SLC6A4—chronic obstructive pulmonary disease	0.000349	0.565	CrCbGaD
Desloratadine—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000348	0.00254	CcSEcCtD
Desloratadine—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000348	0.00254	CcSEcCtD
Desloratadine—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000347	0.00253	CcSEcCtD
Desloratadine—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000347	0.00253	CcSEcCtD
Desloratadine—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000345	0.00251	CcSEcCtD
Desloratadine—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000343	0.00251	CcSEcCtD
Desloratadine—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.00034	0.00248	CcSEcCtD
Desloratadine—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.00034	0.00248	CcSEcCtD
Desloratadine—Oedema—Formoterol—chronic obstructive pulmonary disease	0.00034	0.00248	CcSEcCtD
Desloratadine—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.00034	0.00248	CcSEcCtD
Desloratadine—Infection—Formoterol—chronic obstructive pulmonary disease	0.000338	0.00247	CcSEcCtD
Desloratadine—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000338	0.00247	CcSEcCtD
Desloratadine—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000335	0.00244	CcSEcCtD
Desloratadine—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000335	0.00244	CcSEcCtD
Desloratadine—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000334	0.00243	CcSEcCtD
Desloratadine—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000334	0.00243	CcSEcCtD
Desloratadine—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000333	0.00243	CcSEcCtD
Desloratadine—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000333	0.00243	CcSEcCtD
Desloratadine—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000333	0.00243	CcSEcCtD
Desloratadine—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000332	0.00242	CcSEcCtD
Desloratadine—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000332	0.00242	CcSEcCtD
Desloratadine—Infection—Montelukast—chronic obstructive pulmonary disease	0.000331	0.00241	CcSEcCtD
Desloratadine—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000329	0.0024	CcSEcCtD
Desloratadine—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000328	0.00239	CcSEcCtD
Desloratadine—Hyperkinesia—Prednisone—chronic obstructive pulmonary disease	0.000327	0.00239	CcSEcCtD
Desloratadine—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000327	0.00238	CcSEcCtD
Desloratadine—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000321	0.00234	CcSEcCtD
Desloratadine—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000321	0.00234	CcSEcCtD
Desloratadine—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000319	0.00233	CcSEcCtD
Desloratadine—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000316	0.00231	CcSEcCtD
Desloratadine—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000315	0.0023	CcSEcCtD
Desloratadine—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000314	0.00229	CcSEcCtD
Desloratadine—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000311	0.00227	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.00031	0.00226	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00031	0.00226	CcSEcCtD
Desloratadine—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000308	0.00224	CcSEcCtD
Desloratadine—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000308	0.00224	CcSEcCtD
Desloratadine—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000306	0.00223	CcSEcCtD
Desloratadine—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000306	0.00223	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000304	0.00221	CcSEcCtD
Desloratadine—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000303	0.00221	CcSEcCtD
Desloratadine—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000303	0.00221	CcSEcCtD
Desloratadine—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000302	0.00221	CcSEcCtD
Desloratadine—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000302	0.00221	CcSEcCtD
Desloratadine—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000301	0.0022	CcSEcCtD
Desloratadine—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000299	0.00218	CcSEcCtD
Desloratadine—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000299	0.00218	CcSEcCtD
Desloratadine—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000298	0.00218	CcSEcCtD
Desloratadine—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000296	0.00216	CcSEcCtD
Desloratadine—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000296	0.00216	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000294	0.00214	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000294	0.00214	CcSEcCtD
Desloratadine—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000293	0.00214	CcSEcCtD
Desloratadine—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000293	0.00214	CcSEcCtD
Desloratadine—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000293	0.00214	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000293	0.00213	CcSEcCtD
Desloratadine—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000291	0.00212	CcSEcCtD
Desloratadine—Increased appetite—Prednisone—chronic obstructive pulmonary disease	0.00029	0.00211	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000288	0.0021	CcSEcCtD
Desloratadine—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000287	0.0021	CcSEcCtD
Desloratadine—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000286	0.00209	CcSEcCtD
Desloratadine—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000286	0.00208	CcSEcCtD
Desloratadine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000284	0.00207	CcSEcCtD
Desloratadine—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000283	0.00206	CcSEcCtD
Desloratadine—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000282	0.00206	CcSEcCtD
Desloratadine—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000282	0.00205	CcSEcCtD
Desloratadine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00028	0.00204	CcSEcCtD
Desloratadine—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000279	0.00204	CcSEcCtD
Desloratadine—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000279	0.00203	CcSEcCtD
Desloratadine—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000278	0.00203	CcSEcCtD
Desloratadine—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000278	0.00203	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000277	0.00202	CcSEcCtD
Desloratadine—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000277	0.00202	CcSEcCtD
Desloratadine—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000272	0.00199	CcSEcCtD
Desloratadine—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.00027	0.00197	CcSEcCtD
Desloratadine—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.00027	0.00197	CcSEcCtD
Desloratadine—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000269	0.00196	CcSEcCtD
Desloratadine—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000269	0.00196	CcSEcCtD
Desloratadine—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000269	0.00196	CcSEcCtD
Desloratadine—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000269	0.00196	CcSEcCtD
Desloratadine—Amoxapine—HTR2A—chronic obstructive pulmonary disease	0.000268	0.434	CrCbGaD
Desloratadine—Affect lability—Prednisone—chronic obstructive pulmonary disease	0.000268	0.00196	CcSEcCtD
Desloratadine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000268	0.00196	CcSEcCtD
Desloratadine—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000266	0.00194	CcSEcCtD
Desloratadine—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000266	0.00194	CcSEcCtD
Desloratadine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000266	0.00194	CcSEcCtD
Desloratadine—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000265	0.00193	CcSEcCtD
Desloratadine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000264	0.00193	CcSEcCtD
Desloratadine—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000263	0.00192	CcSEcCtD
Desloratadine—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000263	0.00192	CcSEcCtD
Desloratadine—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000263	0.00192	CcSEcCtD
Desloratadine—Irritability—Prednisone—chronic obstructive pulmonary disease	0.00026	0.0019	CcSEcCtD
Desloratadine—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.000258	0.00188	CcSEcCtD
Desloratadine—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000255	0.00186	CcSEcCtD
Desloratadine—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000254	0.00185	CcSEcCtD
Desloratadine—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000254	0.00185	CcSEcCtD
Desloratadine—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000251	0.00183	CcSEcCtD
Desloratadine—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000251	0.00183	CcSEcCtD
Desloratadine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00025	0.00183	CcSEcCtD
Desloratadine—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000245	0.00179	CcSEcCtD
Desloratadine—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000244	0.00178	CcSEcCtD
Desloratadine—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000244	0.00178	CcSEcCtD
Desloratadine—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000241	0.00176	CcSEcCtD
Desloratadine—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000241	0.00176	CcSEcCtD
Desloratadine—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000239	0.00174	CcSEcCtD
Desloratadine—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000237	0.00173	CcSEcCtD
Desloratadine—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000236	0.00172	CcSEcCtD
Desloratadine—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000233	0.0017	CcSEcCtD
Desloratadine—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000233	0.0017	CcSEcCtD
Desloratadine—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.00023	0.00168	CcSEcCtD
Desloratadine—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000228	0.00166	CcSEcCtD
Desloratadine—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000227	0.00166	CcSEcCtD
Desloratadine—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000226	0.00165	CcSEcCtD
Desloratadine—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000225	0.00164	CcSEcCtD
Desloratadine—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000225	0.00164	CcSEcCtD
Desloratadine—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.00022	0.00161	CcSEcCtD
Desloratadine—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.00022	0.0016	CcSEcCtD
Desloratadine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000216	0.00158	CcSEcCtD
Desloratadine—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000216	0.00158	CcSEcCtD
Desloratadine—Rash—Formoterol—chronic obstructive pulmonary disease	0.000214	0.00156	CcSEcCtD
Desloratadine—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000214	0.00156	CcSEcCtD
Desloratadine—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000214	0.00156	CcSEcCtD
Desloratadine—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000214	0.00156	CcSEcCtD
Desloratadine—Headache—Formoterol—chronic obstructive pulmonary disease	0.000213	0.00155	CcSEcCtD
Desloratadine—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000213	0.00155	CcSEcCtD
Desloratadine—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000212	0.00155	CcSEcCtD
Desloratadine—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000212	0.00155	CcSEcCtD
Desloratadine—Rash—Montelukast—chronic obstructive pulmonary disease	0.00021	0.00153	CcSEcCtD
Desloratadine—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.00021	0.00153	CcSEcCtD
Desloratadine—Headache—Montelukast—chronic obstructive pulmonary disease	0.000209	0.00152	CcSEcCtD
Desloratadine—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000206	0.0015	CcSEcCtD
Desloratadine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000204	0.00149	CcSEcCtD
Desloratadine—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000203	0.00148	CcSEcCtD
Desloratadine—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000202	0.00148	CcSEcCtD
Desloratadine—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000202	0.00147	CcSEcCtD
Desloratadine—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000202	0.00147	CcSEcCtD
Desloratadine—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000201	0.00147	CcSEcCtD
Desloratadine—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000198	0.00144	CcSEcCtD
Desloratadine—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000196	0.00143	CcSEcCtD
Desloratadine—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000191	0.00139	CcSEcCtD
Desloratadine—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.000187	0.00137	CcSEcCtD
Desloratadine—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000185	0.00135	CcSEcCtD
Desloratadine—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000184	0.00134	CcSEcCtD
Desloratadine—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000184	0.00134	CcSEcCtD
Desloratadine—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.00018	0.00131	CcSEcCtD
Desloratadine—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000167	0.00122	CcSEcCtD
Desloratadine—CYP1A2—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000166	0.00733	CbGpPWpGaD
Desloratadine—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000165	0.0012	CcSEcCtD
Desloratadine—Erythema—Prednisone—chronic obstructive pulmonary disease	0.000164	0.0012	CcSEcCtD
Desloratadine—CYP1A2—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000159	0.00705	CbGpPWpGaD
Desloratadine—CYP2C19—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	0.000158	0.00699	CbGpPWpGaD
Desloratadine—CYP2D6—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	0.000155	0.00686	CbGpPWpGaD
Desloratadine—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000151	0.0011	CcSEcCtD
Desloratadine—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.00015	0.00109	CcSEcCtD
Desloratadine—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000146	0.00107	CcSEcCtD
Desloratadine—CYP2D6—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	0.000145	0.00643	CbGpPWpGaD
Desloratadine—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000142	0.00104	CcSEcCtD
Desloratadine—CYP2C19—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000141	0.00622	CbGpPWpGaD
Desloratadine—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.00014	0.00102	CcSEcCtD
Desloratadine—CYP1A2—Aryl Hydrocarbon Receptor—GCLC—chronic obstructive pulmonary disease	0.000139	0.00616	CbGpPWpGaD
Desloratadine—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000136	0.00099	CcSEcCtD
Desloratadine—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000134	0.000977	CcSEcCtD
Desloratadine—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000134	0.000977	CcSEcCtD
Desloratadine—Infection—Prednisone—chronic obstructive pulmonary disease	0.000133	0.00097	CcSEcCtD
Desloratadine—CYP1A2—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	0.000131	0.00581	CbGpPWpGaD
Desloratadine—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000131	0.000958	CcSEcCtD
Desloratadine—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000131	0.000953	CcSEcCtD
Desloratadine—CYP2C9—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000128	0.00567	CbGpPWpGaD
Desloratadine—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000128	0.000931	CcSEcCtD
Desloratadine—CYP2C19—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000124	0.0055	CbGpPWpGaD
Desloratadine—CYP1A2—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	0.000123	0.00545	CbGpPWpGaD
Desloratadine—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000122	0.00089	CcSEcCtD
Desloratadine—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000122	0.000889	CcSEcCtD
Desloratadine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000122	0.00538	CbGpPWpGaD
Desloratadine—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000121	0.000883	CcSEcCtD
Desloratadine—CYP2C19—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.00012	0.00531	CbGpPWpGaD
Desloratadine—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000118	0.00086	CcSEcCtD
Desloratadine—ABCB1—Allograft Rejection—IL13—chronic obstructive pulmonary disease	0.000117	0.00516	CbGpPWpGaD
Desloratadine—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000116	0.000849	CcSEcCtD
Desloratadine—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000116	0.000847	CcSEcCtD
Desloratadine—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000116	0.000847	CcSEcCtD
Desloratadine—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000115	0.000842	CcSEcCtD
Desloratadine—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000115	0.000842	CcSEcCtD
Desloratadine—CYP2D6—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000114	0.00506	CbGpPWpGaD
Desloratadine—CYP2C9—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000113	0.00501	CbGpPWpGaD
Desloratadine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000112	0.00495	CbGpPWpGaD
Desloratadine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000111	0.0049	CbGpPWpGaD
Desloratadine—CYP2D6—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.00011	0.00488	CbGpPWpGaD
Desloratadine—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000109	0.000799	CcSEcCtD
Desloratadine—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000109	0.000798	CcSEcCtD
Desloratadine—CYP2C9—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000109	0.00484	CbGpPWpGaD
Desloratadine—ABCB1—Allograft Rejection—IL17A—chronic obstructive pulmonary disease	0.000107	0.00475	CbGpPWpGaD
Desloratadine—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000106	0.000776	CcSEcCtD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	0.000106	0.00471	CbGpPWpGaD
Desloratadine—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000106	0.000772	CcSEcCtD
Desloratadine—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000106	0.000772	CcSEcCtD
Desloratadine—CYP2C19—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000102	0.00452	CbGpPWpGaD
Desloratadine—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	9.86e-05	0.00072	CcSEcCtD
Desloratadine—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	9.85e-05	0.00436	CbGpPWpGaD
Desloratadine—CYP1A2—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	9.68e-05	0.00429	CbGpPWpGaD
Desloratadine—Asthenia—Prednisone—chronic obstructive pulmonary disease	9.61e-05	0.000701	CcSEcCtD
Desloratadine—Pruritus—Prednisone—chronic obstructive pulmonary disease	9.47e-05	0.000691	CcSEcCtD
Desloratadine—CYP2C9—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	9.31e-05	0.00412	CbGpPWpGaD
Desloratadine—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	9.16e-05	0.000668	CcSEcCtD
Desloratadine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	9.06e-05	0.00401	CbGpPWpGaD
Desloratadine—ABCB1—HIF-1-alpha transcription factor network—HMOX1—chronic obstructive pulmonary disease	9.04e-05	0.004	CbGpPWpGaD
Desloratadine—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	8.98e-05	0.00397	CbGpPWpGaD
Desloratadine—Dizziness—Prednisone—chronic obstructive pulmonary disease	8.85e-05	0.000646	CcSEcCtD
Desloratadine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	8.83e-05	0.00391	CbGpPWpGaD
Desloratadine—CYP2C19—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	8.71e-05	0.00386	CbGpPWpGaD
Desloratadine—ABCB1—HIF-1-alpha transcription factor network—EDN1—chronic obstructive pulmonary disease	8.52e-05	0.00377	CbGpPWpGaD
Desloratadine—Vomiting—Prednisone—chronic obstructive pulmonary disease	8.51e-05	0.000621	CcSEcCtD
Desloratadine—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—chronic obstructive pulmonary disease	8.51e-05	0.00377	CbGpPWpGaD
Desloratadine—CYP1A2—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	8.51e-05	0.00377	CbGpPWpGaD
Desloratadine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	8.51e-05	0.00377	CbGpPWpGaD
Desloratadine—Rash—Prednisone—chronic obstructive pulmonary disease	8.44e-05	0.000616	CcSEcCtD
Desloratadine—Dermatitis—Prednisone—chronic obstructive pulmonary disease	8.43e-05	0.000615	CcSEcCtD
Desloratadine—Headache—Prednisone—chronic obstructive pulmonary disease	8.39e-05	0.000612	CcSEcCtD
Desloratadine—CYP1A2—Phase II conjugation—GSTT1—chronic obstructive pulmonary disease	8.39e-05	0.00371	CbGpPWpGaD
Desloratadine—CYP1A2—Phase II conjugation—GCLC—chronic obstructive pulmonary disease	8.29e-05	0.00367	CbGpPWpGaD
Desloratadine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	8.12e-05	0.00359	CbGpPWpGaD
Desloratadine—HRH1—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	8.1e-05	0.00358	CbGpPWpGaD
Desloratadine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	8.05e-05	0.00356	CbGpPWpGaD
Desloratadine—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	8.01e-05	0.00355	CbGpPWpGaD
Desloratadine—CYP1A2—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	7.96e-05	0.00352	CbGpPWpGaD
Desloratadine—Nausea—Prednisone—chronic obstructive pulmonary disease	7.95e-05	0.00058	CcSEcCtD
Desloratadine—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	7.94e-05	0.00352	CbGpPWpGaD
Desloratadine—ABCB1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	7.82e-05	0.00346	CbGpPWpGaD
Desloratadine—ABCB1—Allograft Rejection—IL10—chronic obstructive pulmonary disease	7.29e-05	0.00323	CbGpPWpGaD
Desloratadine—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	7.16e-05	0.00317	CbGpPWpGaD
Desloratadine—ABCB1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	6.97e-05	0.00308	CbGpPWpGaD
Desloratadine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	6.94e-05	0.00307	CbGpPWpGaD
Desloratadine—ABCB1—HIF-1-alpha transcription factor network—LEP—chronic obstructive pulmonary disease	6.93e-05	0.00307	CbGpPWpGaD
Desloratadine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	6.88e-05	0.00304	CbGpPWpGaD
Desloratadine—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	6.79e-05	0.003	CbGpPWpGaD
Desloratadine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	6.58e-05	0.00291	CbGpPWpGaD
Desloratadine—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	6.53e-05	0.00289	CbGpPWpGaD
Desloratadine—ABCB1—HIF-1-alpha transcription factor network—NOS2—chronic obstructive pulmonary disease	6.46e-05	0.00286	CbGpPWpGaD
Desloratadine—CYP2C19—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	6.3e-05	0.00279	CbGpPWpGaD
Desloratadine—CYP2C19—Biological oxidations—GCLC—chronic obstructive pulmonary disease	6.22e-05	0.00275	CbGpPWpGaD
Desloratadine—HRH1—G alpha (q) signalling events—EDN1—chronic obstructive pulmonary disease	5.87e-05	0.0026	CbGpPWpGaD
Desloratadine—CYP1A2—Phase II conjugation—GSTP1—chronic obstructive pulmonary disease	5.81e-05	0.00257	CbGpPWpGaD
Desloratadine—CYP2D6—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	5.79e-05	0.00256	CbGpPWpGaD
Desloratadine—CYP2C9—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	5.74e-05	0.00254	CbGpPWpGaD
Desloratadine—CYP2D6—Biological oxidations—GCLC—chronic obstructive pulmonary disease	5.72e-05	0.00253	CbGpPWpGaD
Desloratadine—CYP2C9—Biological oxidations—GCLC—chronic obstructive pulmonary disease	5.67e-05	0.00251	CbGpPWpGaD
Desloratadine—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	5.58e-05	0.00247	CbGpPWpGaD
Desloratadine—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—chronic obstructive pulmonary disease	5.44e-05	0.00241	CbGpPWpGaD
Desloratadine—CYP1A2—Phase II conjugation—GSTM1—chronic obstructive pulmonary disease	5.34e-05	0.00236	CbGpPWpGaD
Desloratadine—HRH1—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	5.28e-05	0.00234	CbGpPWpGaD
Desloratadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—chronic obstructive pulmonary disease	5.25e-05	0.00233	CbGpPWpGaD
Desloratadine—CYP2C19—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	5.23e-05	0.00232	CbGpPWpGaD
Desloratadine—CYP2C19—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	5.16e-05	0.00228	CbGpPWpGaD
Desloratadine—HRH1—G alpha (q) signalling events—HTR2A—chronic obstructive pulmonary disease	5.14e-05	0.00227	CbGpPWpGaD
Desloratadine—HRH1—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	5.08e-05	0.00225	CbGpPWpGaD
Desloratadine—CYP1A2—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	4.91e-05	0.00217	CbGpPWpGaD
Desloratadine—CYP1A2—Biological oxidations—GCLC—chronic obstructive pulmonary disease	4.85e-05	0.00215	CbGpPWpGaD
Desloratadine—CYP2D6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	4.81e-05	0.00213	CbGpPWpGaD
Desloratadine—CYP2C9—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	4.77e-05	0.00211	CbGpPWpGaD
Desloratadine—CYP2D6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	4.75e-05	0.0021	CbGpPWpGaD
Desloratadine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	4.71e-05	0.00208	CbGpPWpGaD
Desloratadine—CYP2C9—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	4.71e-05	0.00208	CbGpPWpGaD
Desloratadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—chronic obstructive pulmonary disease	4.6e-05	0.00203	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	4.43e-05	0.00196	CbGpPWpGaD
Desloratadine—CYP2C19—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.36e-05	0.00193	CbGpPWpGaD
Desloratadine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	4.35e-05	0.00193	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	4.33e-05	0.00192	CbGpPWpGaD
Desloratadine—CYP2C19—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4.3e-05	0.0019	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	4.04e-05	0.00179	CbGpPWpGaD
Desloratadine—CYP2D6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.01e-05	0.00178	CbGpPWpGaD
Desloratadine—CYP2C19—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.01e-05	0.00177	CbGpPWpGaD
Desloratadine—ABCB1—Allograft Rejection—CXCL8—chronic obstructive pulmonary disease	3.99e-05	0.00176	CbGpPWpGaD
Desloratadine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	3.99e-05	0.00176	CbGpPWpGaD
Desloratadine—CYP2C9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.98e-05	0.00176	CbGpPWpGaD
Desloratadine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	3.97e-05	0.00176	CbGpPWpGaD
Desloratadine—CYP2D6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.96e-05	0.00175	CbGpPWpGaD
Desloratadine—CYP2C19—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.96e-05	0.00175	CbGpPWpGaD
Desloratadine—CYP2C9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.92e-05	0.00174	CbGpPWpGaD
Desloratadine—HRH1—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	3.89e-05	0.00172	CbGpPWpGaD
Desloratadine—ABCB1—Allograft Rejection—IL1B—chronic obstructive pulmonary disease	3.83e-05	0.00169	CbGpPWpGaD
Desloratadine—CYP2C19—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.8e-05	0.00168	CbGpPWpGaD
Desloratadine—CYP2C19—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.75e-05	0.00166	CbGpPWpGaD
Desloratadine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	3.74e-05	0.00166	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	3.71e-05	0.00164	CbGpPWpGaD
Desloratadine—CYP2D6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.69e-05	0.00163	CbGpPWpGaD
Desloratadine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	3.66e-05	0.00162	CbGpPWpGaD
Desloratadine—CYP2C9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.66e-05	0.00162	CbGpPWpGaD
Desloratadine—CYP2D6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.64e-05	0.00161	CbGpPWpGaD
Desloratadine—CYP2C9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.61e-05	0.0016	CbGpPWpGaD
Desloratadine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	3.59e-05	0.00159	CbGpPWpGaD
Desloratadine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	3.59e-05	0.00159	CbGpPWpGaD
Desloratadine—CYP2D6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.5e-05	0.00155	CbGpPWpGaD
Desloratadine—CYP2C9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.47e-05	0.00153	CbGpPWpGaD
Desloratadine—CYP2D6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.45e-05	0.00153	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	3.45e-05	0.00153	CbGpPWpGaD
Desloratadine—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.42e-05	0.00151	CbGpPWpGaD
Desloratadine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	3.42e-05	0.00151	CbGpPWpGaD
Desloratadine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	3.42e-05	0.00151	CbGpPWpGaD
Desloratadine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	3.4e-05	0.00151	CbGpPWpGaD
Desloratadine—CYP1A2—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.4e-05	0.0015	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	3.36e-05	0.00149	CbGpPWpGaD
Desloratadine—CYP1A2—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.35e-05	0.00148	CbGpPWpGaD
Desloratadine—HRH1—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	3.32e-05	0.00147	CbGpPWpGaD
Desloratadine—ABCB1—Allograft Rejection—VEGFA—chronic obstructive pulmonary disease	3.24e-05	0.00143	CbGpPWpGaD
Desloratadine—CYP1A2—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.12e-05	0.00138	CbGpPWpGaD
Desloratadine—CYP1A2—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.08e-05	0.00136	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—APIP—chronic obstructive pulmonary disease	3.06e-05	0.00135	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	2.99e-05	0.00132	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—APIP—chronic obstructive pulmonary disease	2.99e-05	0.00132	CbGpPWpGaD
Desloratadine—ABCB1—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	2.97e-05	0.00132	CbGpPWpGaD
Desloratadine—HRH1—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	2.96e-05	0.00131	CbGpPWpGaD
Desloratadine—CYP1A2—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.96e-05	0.00131	CbGpPWpGaD
Desloratadine—CYP1A2—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.92e-05	0.00129	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	2.81e-05	0.00124	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	2.79e-05	0.00123	CbGpPWpGaD
Desloratadine—ABCB1—Allograft Rejection—TNF—chronic obstructive pulmonary disease	2.78e-05	0.00123	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	2.71e-05	0.0012	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	2.62e-05	0.00116	CbGpPWpGaD
Desloratadine—HRH1—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	2.59e-05	0.00115	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—APIP—chronic obstructive pulmonary disease	2.38e-05	0.00105	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.18e-05	0.000965	CbGpPWpGaD
Desloratadine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	2.1e-05	0.000931	CbGpPWpGaD
Desloratadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	2.08e-05	0.000918	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.03e-05	0.000897	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.01e-05	0.000889	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.99e-05	0.00088	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	1.99e-05	0.00088	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.98e-05	0.000875	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—GC—chronic obstructive pulmonary disease	1.97e-05	0.000872	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	1.92e-05	0.000851	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	1.87e-05	0.000829	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.86e-05	0.000825	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.85e-05	0.000818	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.83e-05	0.000811	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.83e-05	0.000811	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	1.81e-05	0.000802	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	1.8e-05	0.000795	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.79e-05	0.000791	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	1.7e-05	0.000753	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.7e-05	0.000752	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.69e-05	0.000746	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	1.67e-05	0.000741	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.67e-05	0.000739	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.6e-05	0.000709	CbGpPWpGaD
Desloratadine—HRH1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	1.6e-05	0.000709	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	1.6e-05	0.000707	CbGpPWpGaD
Desloratadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	1.6e-05	0.000706	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.58e-05	0.000699	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	1.54e-05	0.00068	CbGpPWpGaD
Desloratadine—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	1.53e-05	0.000679	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.52e-05	0.000673	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	1.47e-05	0.000649	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	1.46e-05	0.000648	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.46e-05	0.000646	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	1.44e-05	0.000637	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.43e-05	0.000632	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	1.37e-05	0.000606	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.33e-05	0.000589	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.33e-05	0.000589	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	1.21e-05	0.000534	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.17e-05	0.000518	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.14e-05	0.000503	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.09e-05	0.000482	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.08e-05	0.000476	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	1.06e-05	0.000471	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.05e-05	0.000465	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.04e-05	0.00046	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.01e-05	0.000445	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	9.92e-06	0.000439	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.9e-06	0.000438	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.82e-06	0.000434	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	9.79e-06	0.000433	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	9.71e-06	0.00043	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	9.7e-06	0.000429	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	9.48e-06	0.000419	CbGpPWpGaD
Desloratadine—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	9.21e-06	0.000408	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	9.05e-06	0.0004	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	9.05e-06	0.0004	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	8.98e-06	0.000397	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.95e-06	0.000396	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	8.93e-06	0.000395	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	8.86e-06	0.000392	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.73e-06	0.000387	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.39e-06	0.000371	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	8.29e-06	0.000367	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.23e-06	0.000364	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	8.22e-06	0.000364	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	8.16e-06	0.000361	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.16e-06	0.000361	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	7.86e-06	0.000348	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	7.73e-06	0.000342	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	7.57e-06	0.000335	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.46e-06	0.00033	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.36e-06	0.000326	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	7.3e-06	0.000323	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.28e-06	0.000322	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.18e-06	0.000318	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.86e-06	0.000304	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.86e-06	0.000304	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.8e-06	0.000301	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.77e-06	0.0003	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.71e-06	0.000297	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.69e-06	0.000296	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.5e-06	0.000288	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.35e-06	0.000281	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.31e-06	0.000279	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.25e-06	0.000277	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	6.01e-06	0.000266	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.98e-06	0.000265	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.93e-06	0.000262	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.82e-06	0.000257	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.73e-06	0.000254	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.73e-06	0.000254	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.47e-06	0.000242	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.34e-06	0.000236	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.07e-06	0.000224	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.85e-06	0.000215	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.62e-06	0.000204	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	4.42e-06	0.000196	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.39e-06	0.000194	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	4.31e-06	0.000191	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	4.23e-06	0.000187	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	4.13e-06	0.000183	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	4.06e-06	0.00018	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	4.03e-06	0.000178	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.94e-06	0.000174	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	3.89e-06	0.000172	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	3.85e-06	0.000171	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.62e-06	0.00016	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.55e-06	0.000157	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	3.44e-06	0.000152	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	3.29e-06	0.000146	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.98e-06	0.000132	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.73e-06	0.000121	CbGpPWpGaD
